Download PDF
Thromb Haemost 1999; 82(01): 156-157
DOI: 10.1055/s-0037-1614651
Letters to the Editor
Schattauer GmbH

Non-specific Inhibition of ADP-induced Platelet Antiaggregation by Clopidogrel In Vitro

J. M. Herbert
1   From the Haemobiology Dept, Sanofi Recherche, Toulouse, France
,
P. Savi
1   From the Haemobiology Dept, Sanofi Recherche, Toulouse, France
› Author Affiliations
Further Information

Publication History

Received 23 March 1999

Accepted 24 March 1999

Publication Date:
11 December 2017 (online)

Also available at
    Permissions and Reprints

 

 

  • References

  • 1 Weber AA, Reimann S, Schror K. Specific inhibition of ADP-induced platelet aggregation by clopidogrel in vitro. Br J Pharmacol 1999; 126 (02) 415-20.
    CrossrefPubMedGoogle Scholar
  • 2 Herbert JM, Frehel D, Vallée E, Kieffer G, Gouy D, Berger Y, Necciari J, Defreyn G, Maffrand JP. Clopidogrel, a novel antiplatelet and antithrombotic agent. Cardiovasc Drug Rev 1993; 11: 180-98.
    CrossrefPubMedGoogle Scholar
  • 3 Savi P, Herbert JM, Pflieger AM, Dol F, Delebassée D, Combalbert J, Defreyn G, Maffrand JP. Importance of hepatic metabolism in the antiaggregating activity of the thienopyridine clopidogrel. Biochem Pharmacol 1992; 44: 527-32.
    CrossrefPubMedGoogle Scholar
  • 4 Savi P, Combalbert J, Gaich C, Rouchon MC, Maffrand JP, Berger Y, Herbert JM. The antiaggregating activity of clopidogrel is due to a metabolic activation by hepatic cytochrome P450-1A. Thromb Haemost 1994; 72: 313-7.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 5 Defreyn G, Gachet C, Savi P, Driot F, Cazenave JP, Maffrand JP. Ticlopidine and clopidogrel (SR 25990C) selectively neutralize ADP inhibition of PGE1-activated platelet adenylate cyclase in rats and rabbits. Thromb Haemost 1991; 65: 186-90.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 6 Holme S, Sixma JJ, Wester J, Holmsen H. ADP-induced refractory state of platelets in vitro. II-Functional and ultra studies on gel filtered platelets. Scand J Haematol 1977; 18: 267-78.
    PubMedGoogle Scholar
  • 7 Mills DCB, Puri R, Hu C-J, Minniti C, Grana G, Freedman MD, Colman RF, Colman RW. Clopidogrel inhibits the binding of ADP analogues to the receptor mediating inhibition of platelet adenylate cyclase. Arteriosclerosis and thrombosis 1992; 12: 430-6.
    CrossrefPubMedGoogle Scholar
  • 8 Savi P, Laplace MC, Maffrand JP, Herbert JM. Binding of 3H-2-methylthio ADP to rat platelets: effect of clopidogrel and ticlopidine. J Pharm Exp Ther 1994; 269: 772-7.
    PubMedGoogle Scholar
  • 9 Gambino MC, Passaghe S, Chen ZM, Bucchi F, Gori G, Latini R, De Gaetano G, Cerletti C. Selectivity of oral aspirin as an inhibitor of platelet vs. vascular cyclooxygenase activity is reduced by portacaval shunt in rats. J Pharmacol Exp Ther 1988; 245: 287-90.
    PubMedGoogle Scholar
  • 10 Savi P, Pereillo JM, Fedeli O, Maftouh M, Uzabiaga MF, Berger Y, Necciari J, Rouchon MC, Combalbert J, Picard C, Maffrand JP, Pascal M, Herbert JM. Structure and Activity of the Active Metabolite of Clopidogrel. Submitted
    Google Scholar